Conversely, in tumors derived from the phosphomimetic DUSP10 overexpressing cells, PP242 treatment markedly reduced tumor size, increased apoptotic induction, blunted p38 signaling and increased DUSP10 expression. The gene discussed is MAPK14; the disease is neoplasm.